DETAILS, FICTION AND CHEMICAL NAME OF KETAMINE

While in the secondary analysis, the a lot less conservative but clinically meaningful criterion of secure reaction (defined to be a fifty% or more reduction in MADRS from baseline for two months) was used. In the patients who achieved secure response, twenty five.eight% in the esketamine group and fifty seven.6% within the placebo group relapsed,